{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0005393,73,MONDO:0005393,124,-1]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0005393","source":"MONDO:0005393|gout","targets":["NCT00142558|A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00170781|Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout|COMPLETED|PHASE4|INTERVENTIONAL","NCT00180206|Birmingham Hip Resurfacing (BHR) Study: Implantation of a Hip Resurfacing Endoprosthesis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00236366|A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, Compared With Placebo in Patients With Osteoarthritis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00291915|Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00510536|Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab|COMPLETED|PHASE4|INTERVENTIONAL","NCT00524160|A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, in Patients With Rheumatoid Arthritis or Osteoarthritis|COMPLETED|PHASE4|INTERVENTIONAL","NCT00696059|Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?|COMPLETED|PHASE4|INTERVENTIONAL","NCT01027286|Prospective Evaluation of Vitagel for Reduction in Blood Loss and Pain Following Unilateral Total Knee Arthroplasty|COMPLETED|PHASE4|INTERVENTIONAL","NCT01112982|An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.|COMPLETED|PHASE4|INTERVENTIONAL","NCT01264965|Non-cancer Pain and Cognitive Impairment: A Disabling Relationship|TERMINATED|PHASE4|INTERVENTIONAL","NCT01270620|Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee Replacement|COMPLETED|PHASE4|INTERVENTIONAL","NCT01275014|Corticosteroids as Additive in Temporomandibular Joint (TMJ) Arthrocentesis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01310673|Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout|COMPLETED|PHASE4|INTERVENTIONAL","NCT01391325|Allopurinol Outcome Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT01414569|Dexamethasone for Pain After Shoulder Surgery|COMPLETED|PHASE4|INTERVENTIONAL","NCT01472692|Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure|COMPLETED|PHASE4|INTERVENTIONAL","NCT01529099|Postmarketing Study to Determine Performance of the SIGMA HP® PARTIAL KNEE SYSTEM|COMPLETED|PHASE4|INTERVENTIONAL","NCT01654276|Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome|COMPLETED|PHASE4|INTERVENTIONAL","NCT01988402|Does Allopurinol Prolong a Treated, Acute Gout Flare?|COMPLETED|PHASE4|INTERVENTIONAL","NCT01994226|Colchicine Or Naproxen Treatment for ACute gouT|COMPLETED|PHASE4|INTERVENTIONAL","NCT02011464|Evaluation Exparel Delivered in Knee Replacement|COMPLETED|PHASE4|INTERVENTIONAL","NCT02060552|Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels|COMPLETED|PHASE4|INTERVENTIONAL","NCT02462421|Pharmacogenetics of SGLT2 Inhibitors|TERMINATED|PHASE4|INTERVENTIONAL","NCT02477488|Optimal Administration of Allopurinol in Dialysis Patients|COMPLETED|PHASE4|INTERVENTIONAL","NCT02500641|Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout|COMPLETED|PHASE4|INTERVENTIONAL","NCT02579096|CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat|COMPLETED|PHASE4|INTERVENTIONAL","NCT02697955|The Effect of Subsartorial Saphenous Block on Postoperative Pain Following Major Ankle and Hind Foot Surgery|COMPLETED|PHASE4|INTERVENTIONAL","NCT02926651|Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT02956278|The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics|COMPLETED|PHASE4|INTERVENTIONAL","NCT03226899|A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment|TERMINATED|PHASE4|INTERVENTIONAL","NCT03336203|The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF)|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03635957|Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout|COMPLETED|PHASE4|INTERVENTIONAL","NCT03659318|Robotic-Assisted Versus Conventional Total Knee Arthroplasty(TKA)|COMPLETED|PHASE4|INTERVENTIONAL","NCT03994731|Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout|COMPLETED|PHASE4|INTERVENTIONAL","NCT04511702|Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate|COMPLETED|PHASE4|INTERVENTIONAL","NCT04762498|A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)|COMPLETED|PHASE4|INTERVENTIONAL","NCT04875702|Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout|RECRUITING|PHASE4|INTERVENTIONAL","NCT05292339|Ketorolac in Upper Extremity Tendinopathy and Arthropathy|RECRUITING|PHASE4|INTERVENTIONAL","NCT05312268|Rasburicase Treatment in Chronic Gouty Arthritis|UNKNOWN|PHASE4|INTERVENTIONAL","NCT05698680|Prednisolone Versus Colchicine for Acute Gout in Primary Care|RECRUITING|PHASE4|INTERVENTIONAL","NCT06229145|A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout|ACTIVE_NOT_RECRUITING|PHASE4|INTERVENTIONAL","NCT06622603|The Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More|NOT_YET_RECRUITING|PHASE4|INTERVENTIONAL","NCT07346079|Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares|RECRUITING|PHASE4|INTERVENTIONAL","NCT00102440|Febuxostat Versus Allopurinol Control Trial in Subjects With Gout|COMPLETED|PHASE3|INTERVENTIONAL","NCT00146367|Evaluation of the Active Living Every Day Exercise Program for People With Arthritis|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00146393|Health Benefits of an Exercise Program for Adults With Arthritis|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00153309|Program Evaluation of People With Arthritis Can Exercise|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00153660|Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients|COMPLETED|PHASE3|INTERVENTIONAL","NCT00153673|Effect of Selective COX-2 Inhibition on Ulcer Healing|COMPLETED|PHASE3|INTERVENTIONAL","NCT00174915|Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.|COMPLETED|PHASE3|INTERVENTIONAL","NCT00175019|Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010|COMPLETED|PHASE3|INTERVENTIONAL","NCT00211718|Intra-Articular Injection of Botulinum Toxin Type A for Shoulder Pain|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00252070|Fitness and Exercise for People With Arthritis|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00313365|Surgical Lavage vs Serial Needle Aspiration for Infected Joints|WITHDRAWN|PHASE3|INTERVENTIONAL","NCT00325195|Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout|COMPLETED|PHASE3|INTERVENTIONAL","NCT00365313|Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib|COMPLETED|PHASE3|INTERVENTIONAL","NCT00430248|Efficacy and Safety of Oral Febuxostat in Participants With Gout|COMPLETED|PHASE3|INTERVENTIONAL","NCT00506883|MPC-004 for the Treatment of an Acute Gout Flare|COMPLETED|PHASE3|INTERVENTIONAL","NCT00521963|Intraarticular Injection of Infliximab|WITHDRAWN|PHASE2/PHASE3|INTERVENTIONAL","NCT00526201|Help Arthritis With Exercise in West Virginia|COMPLETED|PHASE3|INTERVENTIONAL","NCT00526435|Evaluation of Walk With Ease in Arthritis|COMPLETED|PHASE3|INTERVENTIONAL","NCT00646178|Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy|COMPLETED|PHASE3|INTERVENTIONAL","NCT00733902|Tanezumab in Osteoarthritis of the Knee|COMPLETED|PHASE3|INTERVENTIONAL","NCT00744471|Tanezumab in Osteoarthritis Of The Hip|COMPLETED|PHASE3|INTERVENTIONAL","NCT00765362|Mobile - Bearing Knee Study|COMPLETED|PHASE3|INTERVENTIONAL","NCT00784277|A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint Disease|COMPLETED|PHASE3|INTERVENTIONAL","NCT00809354|Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip|TERMINATED|PHASE3|INTERVENTIONAL","NCT00821392|Phase III Trial of Febuxostat in Korea Gout Patients|COMPLETED|PHASE3|INTERVENTIONAL","NCT00830063|Tanezumab In Osteoarthritis Of The Knee (2)|COMPLETED|PHASE3|INTERVENTIONAL","NCT00856206|Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)|COMPLETED|PHASE3|INTERVENTIONAL","NCT00958438|PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2)|COMPLETED|PHASE3|INTERVENTIONAL","NCT01004432|Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)|COMPLETED|PHASE3|INTERVENTIONAL","NCT01029652|Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study|COMPLETED|PHASE3|INTERVENTIONAL","NCT01080131|Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.|COMPLETED|PHASE3|INTERVENTIONAL","NCT01089725|Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study|TERMINATED|PHASE3|INTERVENTIONAL","NCT01094886|Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement|COMPLETED|PHASE3|INTERVENTIONAL","NCT01356498|Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout|COMPLETED|PHASE3|INTERVENTIONAL","NCT01356602|Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients|COMPLETED|PHASE3|INTERVENTIONAL","NCT01362608|Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective|TERMINATED|PHASE3|INTERVENTIONAL","NCT01431638|Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients|COMPLETED|PHASE3|INTERVENTIONAL","NCT01459796|Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares|TERMINATED|PHASE3|INTERVENTIONAL","NCT01493531|Combining Lesinurad With Allopurinol in Inadequate Responders|COMPLETED|PHASE3|INTERVENTIONAL","NCT01508702|Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors|COMPLETED|PHASE3|INTERVENTIONAL","NCT01510158|Combining Lesinurad With Allopurinol in Inadequate Responders|COMPLETED|PHASE3|INTERVENTIONAL","NCT01510769|Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat|COMPLETED|PHASE3|INTERVENTIONAL","NCT01593527|Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease|WITHDRAWN|PHASE3|INTERVENTIONAL","NCT01615991|Multicentre Canadian Study to Measure the Safety and Efficacy of Radiosynoviorthesis|COMPLETED|PHASE3|INTERVENTIONAL","NCT01650246|Open-Label Lesinurad Monotherapy Extension Study in Gout|COMPLETED|PHASE3|INTERVENTIONAL","NCT01736514|A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout|COMPLETED|PHASE3|INTERVENTIONAL","NCT01808131|Lesinurad and Allopurinol Combination Extension Study in Gout|COMPLETED|PHASE3|INTERVENTIONAL","NCT01808144|Lesinurad and Febuxostat Combination Extension Study in Gout|COMPLETED|PHASE3|INTERVENTIONAL","NCT02082769|Safety and Efficacy of Oral Febuxostat in Subjects With Gout|COMPLETED|PHASE3|INTERVENTIONAL","NCT02139046|Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout|COMPLETED|PHASE3|INTERVENTIONAL","NCT02202967|Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs|COMPLETED|PHASE3|INTERVENTIONAL","NCT02305966|Evaluation of Implant Fixation in Reverse Total Shoulder Arthroplasty|UNKNOWN|PHASE3|INTERVENTIONAL","NCT02578394|Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT02674776|Efficacy and Safety of HuZhen Capsule for Treatment of Patients With Acute Gout|UNKNOWN|PHASE3|INTERVENTIONAL","NCT02778906|Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia|COMPLETED|PHASE3|INTERVENTIONAL","NCT02809781|A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL"]}]}